nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—migraine—Prednisone—chronic obstructive pulmonary disease	0.147	0.508	CpDpCtD
Diclofenac—CXCL8—chronic obstructive pulmonary disease	0.143	0.459	CbGaD
Diclofenac—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.143	0.492	CpDpCtD
Diclofenac—ALOX5—Montelukast—chronic obstructive pulmonary disease	0.0803	0.35	CbGbCtD
Diclofenac—CYP1A1—chronic obstructive pulmonary disease	0.0668	0.214	CbGaD
Diclofenac—CYP1A2—chronic obstructive pulmonary disease	0.0644	0.207	CbGaD
Diclofenac—ALB—chronic obstructive pulmonary disease	0.0372	0.119	CbGaD
Diclofenac—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0181	0.0787	CbGbCtD
Diclofenac—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0156	0.0682	CbGbCtD
Diclofenac—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0115	0.0502	CbGbCtD
Diclofenac—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0115	0.0502	CbGbCtD
Diclofenac—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0104	0.0454	CbGbCtD
Diclofenac—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.00959	0.0418	CbGbCtD
Diclofenac—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.00959	0.0418	CbGbCtD
Diclofenac—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.00905	0.0394	CbGbCtD
Diclofenac—ALB—Prednisone—chronic obstructive pulmonary disease	0.00747	0.0325	CbGbCtD
Diclofenac—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00736	0.0321	CbGbCtD
Diclofenac—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.00727	0.0317	CbGbCtD
Diclofenac—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00497	0.0217	CbGbCtD
Diclofenac—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00484	0.0211	CbGbCtD
Diclofenac—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00474	0.0207	CbGbCtD
Diclofenac—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00423	0.0184	CbGbCtD
Diclofenac—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00414	0.018	CbGbCtD
Diclofenac—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00391	0.017	CbGbCtD
Diclofenac—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00248	0.0108	CbGbCtD
Diclofenac—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00234	0.0102	CbGbCtD
Diclofenac—CXCR1—lung—chronic obstructive pulmonary disease	0.00119	0.0644	CbGeAlD
Diclofenac—PTGS2—leg—chronic obstructive pulmonary disease	0.000852	0.0459	CbGeAlD
Diclofenac—PLA2G2A—respiratory system—chronic obstructive pulmonary disease	0.000806	0.0435	CbGeAlD
Diclofenac—PLA2G2A—connective tissue—chronic obstructive pulmonary disease	0.00071	0.0383	CbGeAlD
Diclofenac—PLA2G2A—bronchus—chronic obstructive pulmonary disease	0.000664	0.0358	CbGeAlD
Diclofenac—CXCL8—bronchus—chronic obstructive pulmonary disease	0.000657	0.0354	CbGeAlD
Diclofenac—PLA2G2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000649	0.035	CbGeAlD
Diclofenac—CXCL8—smooth muscle tissue—chronic obstructive pulmonary disease	0.000643	0.0347	CbGeAlD
Diclofenac—TTR—respiratory system—chronic obstructive pulmonary disease	0.000609	0.0328	CbGeAlD
Diclofenac—CYP2C18—bronchus—chronic obstructive pulmonary disease	0.000606	0.0327	CbGeAlD
Diclofenac—PLA2G2A—trachea—chronic obstructive pulmonary disease	0.000596	0.0321	CbGeAlD
Diclofenac—CXCL8—trachea—chronic obstructive pulmonary disease	0.00059	0.0318	CbGeAlD
Diclofenac—KCNQ3—lung—chronic obstructive pulmonary disease	0.000565	0.0305	CbGeAlD
Diclofenac—ALOX5—respiratory system—chronic obstructive pulmonary disease	0.000552	0.0297	CbGeAlD
Diclofenac—TTR—connective tissue—chronic obstructive pulmonary disease	0.000536	0.0289	CbGeAlD
Diclofenac—ALOX5—connective tissue—chronic obstructive pulmonary disease	0.000486	0.0262	CbGeAlD
Diclofenac—ALOX5—bronchus—chronic obstructive pulmonary disease	0.000454	0.0245	CbGeAlD
Diclofenac—Lumiracoxib—CYP1A2—chronic obstructive pulmonary disease	0.000446	0.432	CrCbGaD
Diclofenac—ALOX5—smooth muscle tissue—chronic obstructive pulmonary disease	0.000444	0.024	CbGeAlD
Diclofenac—PLA2G2A—lung—chronic obstructive pulmonary disease	0.000428	0.0231	CbGeAlD
Diclofenac—CXCL8—lung—chronic obstructive pulmonary disease	0.000424	0.0229	CbGeAlD
Diclofenac—TTR—lung—chronic obstructive pulmonary disease	0.000323	0.0174	CbGeAlD
Diclofenac—ABCC4—bronchus—chronic obstructive pulmonary disease	0.00031	0.0167	CbGeAlD
Diclofenac—Clonidine—CYP1A1—chronic obstructive pulmonary disease	0.000298	0.289	CrCbGaD
Diclofenac—ALOX5—lung—chronic obstructive pulmonary disease	0.000293	0.0158	CbGeAlD
Diclofenac—Clonidine—CYP1A2—chronic obstructive pulmonary disease	0.000288	0.279	CrCbGaD
Diclofenac—ABCC1—bronchus—chronic obstructive pulmonary disease	0.000264	0.0142	CbGeAlD
Diclofenac—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000255	0.0138	CbGeAlD
Diclofenac—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000252	0.0136	CbGeAlD
Diclofenac—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000245	0.0132	CbGeAlD
Diclofenac—ABCC1—trachea—chronic obstructive pulmonary disease	0.000237	0.0128	CbGeAlD
Diclofenac—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.00023	0.0124	CbGeAlD
Diclofenac—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000221	0.0119	CbGeAlD
Diclofenac—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000212	0.0114	CbGeAlD
Diclofenac—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000207	0.0112	CbGeAlD
Diclofenac—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000202	0.0109	CbGeAlD
Diclofenac—ABCC4—lung—chronic obstructive pulmonary disease	0.0002	0.0108	CbGeAlD
Diclofenac—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000195	0.0105	CbGeAlD
Diclofenac—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000186	0.01	CbGeAlD
Diclofenac—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000186	0.01	CbGeAlD
Diclofenac—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000178	0.00962	CbGeAlD
Diclofenac—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000174	0.00939	CbGeAlD
Diclofenac—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00017	0.00919	CbGeAlD
Diclofenac—ABCC1—lung—chronic obstructive pulmonary disease	0.00017	0.00918	CbGeAlD
Diclofenac—PTGS1—trachea—chronic obstructive pulmonary disease	0.000164	0.00882	CbGeAlD
Diclofenac—PTGS2—trachea—chronic obstructive pulmonary disease	0.000156	0.00843	CbGeAlD
Diclofenac—CYP1A2—lung—chronic obstructive pulmonary disease	0.000136	0.00732	CbGeAlD
Diclofenac—CYP1A1—lung—chronic obstructive pulmonary disease	0.000134	0.00722	CbGeAlD
Diclofenac—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000131	0.00706	CbGeAlD
Diclofenac—CYP2B6—lung—chronic obstructive pulmonary disease	0.00013	0.00701	CbGeAlD
Diclofenac—CYP2E1—lung—chronic obstructive pulmonary disease	0.000122	0.00658	CbGeAlD
Diclofenac—PTGS1—lung—chronic obstructive pulmonary disease	0.000118	0.00634	CbGeAlD
Diclofenac—PTGS2—lung—chronic obstructive pulmonary disease	0.000112	0.00606	CbGeAlD
Diclofenac—ABCB1—trachea—chronic obstructive pulmonary disease	9.67e-05	0.00522	CbGeAlD
Diclofenac—ABCB1—lung—chronic obstructive pulmonary disease	6.95e-05	0.00375	CbGeAlD
Diclofenac—Sepsis—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000662	CcSEcCtD
Diclofenac—Skin disorder—Montelukast—chronic obstructive pulmonary disease	6.2e-05	0.000658	CcSEcCtD
Diclofenac—Oedema—Salbutamol—chronic obstructive pulmonary disease	6.15e-05	0.000653	CcSEcCtD
Diclofenac—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	6.15e-05	0.000653	CcSEcCtD
Diclofenac—Infection—Salbutamol—chronic obstructive pulmonary disease	6.11e-05	0.000648	CcSEcCtD
Diclofenac—Hypotension—Formoterol—chronic obstructive pulmonary disease	6.09e-05	0.000646	CcSEcCtD
Diclofenac—Hypotension—Arformoterol—chronic obstructive pulmonary disease	6.09e-05	0.000646	CcSEcCtD
Diclofenac—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	6.08e-05	0.000645	CcSEcCtD
Diclofenac—Pruritus—Aminophylline—chronic obstructive pulmonary disease	6.05e-05	0.000643	CcSEcCtD
Diclofenac—Shock—Salbutamol—chronic obstructive pulmonary disease	6.05e-05	0.000642	CcSEcCtD
Diclofenac—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	6.04e-05	0.000641	CcSEcCtD
Diclofenac—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	6.03e-05	0.00064	CcSEcCtD
Diclofenac—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	6e-05	0.000637	CcSEcCtD
Diclofenac—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	5.97e-05	0.000634	CcSEcCtD
Diclofenac—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	5.95e-05	0.000631	CcSEcCtD
Diclofenac—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	5.95e-05	0.000631	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	5.93e-05	0.00063	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	5.93e-05	0.00063	CcSEcCtD
Diclofenac—Insomnia—Formoterol—chronic obstructive pulmonary disease	5.89e-05	0.000625	CcSEcCtD
Diclofenac—Insomnia—Arformoterol—chronic obstructive pulmonary disease	5.89e-05	0.000625	CcSEcCtD
Diclofenac—Anorexia—Salbutamol—chronic obstructive pulmonary disease	5.86e-05	0.000622	CcSEcCtD
Diclofenac—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	5.86e-05	0.000621	CcSEcCtD
Diclofenac—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	5.83e-05	0.000619	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	5.81e-05	0.000617	CcSEcCtD
Diclofenac—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	5.81e-05	0.000616	CcSEcCtD
Diclofenac—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	5.81e-05	0.000616	CcSEcCtD
Diclofenac—Somnolence—Formoterol—chronic obstructive pulmonary disease	5.79e-05	0.000615	CcSEcCtD
Diclofenac—Somnolence—Arformoterol—chronic obstructive pulmonary disease	5.79e-05	0.000615	CcSEcCtD
Diclofenac—Insomnia—Montelukast—chronic obstructive pulmonary disease	5.77e-05	0.000612	CcSEcCtD
Diclofenac—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	5.75e-05	0.00061	CcSEcCtD
Diclofenac—Hypotension—Salbutamol—chronic obstructive pulmonary disease	5.75e-05	0.00061	CcSEcCtD
Diclofenac—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	5.73e-05	0.000608	CcSEcCtD
Diclofenac—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	5.73e-05	0.000608	CcSEcCtD
Diclofenac—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	5.73e-05	0.000608	CcSEcCtD
Diclofenac—Pruritus—Tiotropium—chronic obstructive pulmonary disease	5.71e-05	0.000606	CcSEcCtD
Diclofenac—Injury—Prednisone—chronic obstructive pulmonary disease	5.67e-05	0.000602	CcSEcCtD
Diclofenac—Somnolence—Montelukast—chronic obstructive pulmonary disease	5.67e-05	0.000602	CcSEcCtD
Diclofenac—Dizziness—Aminophylline—chronic obstructive pulmonary disease	5.66e-05	0.000601	CcSEcCtD
Diclofenac—Weight increased—Prednisolone—chronic obstructive pulmonary disease	5.64e-05	0.000599	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	5.62e-05	0.000597	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	5.62e-05	0.000597	CcSEcCtD
Diclofenac—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	5.62e-05	0.000596	CcSEcCtD
Diclofenac—Fatigue—Formoterol—chronic obstructive pulmonary disease	5.62e-05	0.000596	CcSEcCtD
Diclofenac—Fatigue—Arformoterol—chronic obstructive pulmonary disease	5.62e-05	0.000596	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	5.6e-05	0.000595	CcSEcCtD
Diclofenac—Constipation—Arformoterol—chronic obstructive pulmonary disease	5.57e-05	0.000591	CcSEcCtD
Diclofenac—Pain—Formoterol—chronic obstructive pulmonary disease	5.57e-05	0.000591	CcSEcCtD
Diclofenac—Pain—Arformoterol—chronic obstructive pulmonary disease	5.57e-05	0.000591	CcSEcCtD
Diclofenac—Constipation—Formoterol—chronic obstructive pulmonary disease	5.57e-05	0.000591	CcSEcCtD
Diclofenac—Insomnia—Salbutamol—chronic obstructive pulmonary disease	5.56e-05	0.00059	CcSEcCtD
Diclofenac—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	5.52e-05	0.000586	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	5.51e-05	0.000585	CcSEcCtD
Diclofenac—Fatigue—Montelukast—chronic obstructive pulmonary disease	5.5e-05	0.000584	CcSEcCtD
Diclofenac—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	5.48e-05	0.000582	CcSEcCtD
Diclofenac—Somnolence—Salbutamol—chronic obstructive pulmonary disease	5.47e-05	0.00058	CcSEcCtD
Diclofenac—Pain—Montelukast—chronic obstructive pulmonary disease	5.46e-05	0.000579	CcSEcCtD
Diclofenac—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	5.45e-05	0.000579	CcSEcCtD
Diclofenac—Vomiting—Aminophylline—chronic obstructive pulmonary disease	5.44e-05	0.000577	CcSEcCtD
Diclofenac—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	5.42e-05	0.000575	CcSEcCtD
Diclofenac—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	5.42e-05	0.000575	CcSEcCtD
Diclofenac—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	5.41e-05	0.000575	CcSEcCtD
Diclofenac—Purpura—Prednisone—chronic obstructive pulmonary disease	5.41e-05	0.000574	CcSEcCtD
Diclofenac—Rash—Aminophylline—chronic obstructive pulmonary disease	5.4e-05	0.000573	CcSEcCtD
Diclofenac—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	5.39e-05	0.000572	CcSEcCtD
Diclofenac—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	5.38e-05	0.000571	CcSEcCtD
Diclofenac—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	5.37e-05	0.00057	CcSEcCtD
Diclofenac—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	5.37e-05	0.00057	CcSEcCtD
Diclofenac—Headache—Aminophylline—chronic obstructive pulmonary disease	5.36e-05	0.000569	CcSEcCtD
Diclofenac—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	5.35e-05	0.000567	CcSEcCtD
Diclofenac—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	5.34e-05	0.000567	CcSEcCtD
Diclofenac—Dizziness—Tiotropium—chronic obstructive pulmonary disease	5.34e-05	0.000566	CcSEcCtD
Diclofenac—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	5.33e-05	0.000565	CcSEcCtD
Diclofenac—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	5.33e-05	0.000565	CcSEcCtD
Diclofenac—Lethargy—Prednisone—chronic obstructive pulmonary disease	5.32e-05	0.000565	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	5.31e-05	0.000563	CcSEcCtD
Diclofenac—Fatigue—Salbutamol—chronic obstructive pulmonary disease	5.3e-05	0.000563	CcSEcCtD
Diclofenac—Pain—Salbutamol—chronic obstructive pulmonary disease	5.26e-05	0.000558	CcSEcCtD
Diclofenac—Constipation—Salbutamol—chronic obstructive pulmonary disease	5.26e-05	0.000558	CcSEcCtD
Diclofenac—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	5.22e-05	0.000554	CcSEcCtD
Diclofenac—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.000553	CcSEcCtD
Diclofenac—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.000553	CcSEcCtD
Diclofenac—Urticaria—Arformoterol—chronic obstructive pulmonary disease	5.17e-05	0.000549	CcSEcCtD
Diclofenac—Urticaria—Formoterol—chronic obstructive pulmonary disease	5.17e-05	0.000549	CcSEcCtD
Diclofenac—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	5.15e-05	0.000546	CcSEcCtD
Diclofenac—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	5.15e-05	0.000546	CcSEcCtD
Diclofenac—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	5.15e-05	0.000546	CcSEcCtD
Diclofenac—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	5.15e-05	0.000546	CcSEcCtD
Diclofenac—Vomiting—Tiotropium—chronic obstructive pulmonary disease	5.13e-05	0.000545	CcSEcCtD
Diclofenac—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000541	CcSEcCtD
Diclofenac—Rash—Tiotropium—chronic obstructive pulmonary disease	5.09e-05	0.00054	CcSEcCtD
Diclofenac—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	5.08e-05	0.00054	CcSEcCtD
Diclofenac—Nausea—Aminophylline—chronic obstructive pulmonary disease	5.08e-05	0.000539	CcSEcCtD
Diclofenac—Urticaria—Montelukast—chronic obstructive pulmonary disease	5.07e-05	0.000538	CcSEcCtD
Diclofenac—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	5.07e-05	0.000538	CcSEcCtD
Diclofenac—Headache—Tiotropium—chronic obstructive pulmonary disease	5.06e-05	0.000537	CcSEcCtD
Diclofenac—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	5.05e-05	0.000536	CcSEcCtD
Diclofenac—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	5.04e-05	0.000535	CcSEcCtD
Diclofenac—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	5.04e-05	0.000535	CcSEcCtD
Diclofenac—Face oedema—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000534	CcSEcCtD
Diclofenac—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	5.03e-05	0.000534	CcSEcCtD
Diclofenac—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	4.99e-05	0.00053	CcSEcCtD
Diclofenac—Irritability—Prednisone—chronic obstructive pulmonary disease	4.98e-05	0.000528	CcSEcCtD
Diclofenac—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	4.96e-05	0.000527	CcSEcCtD
Diclofenac—Urticaria—Salbutamol—chronic obstructive pulmonary disease	4.89e-05	0.000519	CcSEcCtD
Diclofenac—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	4.86e-05	0.000516	CcSEcCtD
Diclofenac—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	4.86e-05	0.000516	CcSEcCtD
Diclofenac—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	4.8e-05	0.000509	CcSEcCtD
Diclofenac—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	4.8e-05	0.000509	CcSEcCtD
Diclofenac—Nausea—Tiotropium—chronic obstructive pulmonary disease	4.79e-05	0.000509	CcSEcCtD
Diclofenac—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	4.78e-05	0.000508	CcSEcCtD
Diclofenac—Dry skin—Prednisone—chronic obstructive pulmonary disease	4.78e-05	0.000507	CcSEcCtD
Diclofenac—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	4.7e-05	0.000499	CcSEcCtD
Diclofenac—Asthenia—Arformoterol—chronic obstructive pulmonary disease	4.67e-05	0.000496	CcSEcCtD
Diclofenac—Asthenia—Formoterol—chronic obstructive pulmonary disease	4.67e-05	0.000496	CcSEcCtD
Diclofenac—Pruritus—Formoterol—chronic obstructive pulmonary disease	4.61e-05	0.000489	CcSEcCtD
Diclofenac—Pruritus—Arformoterol—chronic obstructive pulmonary disease	4.61e-05	0.000489	CcSEcCtD
Diclofenac—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.000488	CcSEcCtD
Diclofenac—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.000488	CcSEcCtD
Diclofenac—Asthenia—Montelukast—chronic obstructive pulmonary disease	4.58e-05	0.000486	CcSEcCtD
Diclofenac—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	4.54e-05	0.000482	CcSEcCtD
Diclofenac—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	4.53e-05	0.000481	CcSEcCtD
Diclofenac—Pruritus—Montelukast—chronic obstructive pulmonary disease	4.51e-05	0.000479	CcSEcCtD
Diclofenac—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	4.46e-05	0.000473	CcSEcCtD
Diclofenac—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	4.46e-05	0.000473	CcSEcCtD
Diclofenac—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	4.44e-05	0.000471	CcSEcCtD
Diclofenac—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	4.42e-05	0.000469	CcSEcCtD
Diclofenac—Asthenia—Salbutamol—chronic obstructive pulmonary disease	4.41e-05	0.000468	CcSEcCtD
Diclofenac—Sweating increased—Prednisone—chronic obstructive pulmonary disease	4.39e-05	0.000466	CcSEcCtD
Diclofenac—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	4.36e-05	0.000463	CcSEcCtD
Diclofenac—Pruritus—Salbutamol—chronic obstructive pulmonary disease	4.35e-05	0.000462	CcSEcCtD
Diclofenac—Erythema—Prednisolone—chronic obstructive pulmonary disease	4.32e-05	0.000459	CcSEcCtD
Diclofenac—Dizziness—Formoterol—chronic obstructive pulmonary disease	4.31e-05	0.000457	CcSEcCtD
Diclofenac—Dizziness—Arformoterol—chronic obstructive pulmonary disease	4.31e-05	0.000457	CcSEcCtD
Diclofenac—Dizziness—Montelukast—chronic obstructive pulmonary disease	4.22e-05	0.000448	CcSEcCtD
Diclofenac—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	4.21e-05	0.000447	CcSEcCtD
Diclofenac—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	4.15e-05	0.000441	CcSEcCtD
Diclofenac—Vomiting—Arformoterol—chronic obstructive pulmonary disease	4.14e-05	0.000439	CcSEcCtD
Diclofenac—Vomiting—Formoterol—chronic obstructive pulmonary disease	4.14e-05	0.000439	CcSEcCtD
Diclofenac—Rash—Arformoterol—chronic obstructive pulmonary disease	4.11e-05	0.000436	CcSEcCtD
Diclofenac—Rash—Formoterol—chronic obstructive pulmonary disease	4.11e-05	0.000436	CcSEcCtD
Diclofenac—Dermatitis—Formoterol—chronic obstructive pulmonary disease	4.1e-05	0.000435	CcSEcCtD
Diclofenac—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	4.1e-05	0.000435	CcSEcCtD
Diclofenac—Weight increased—Prednisone—chronic obstructive pulmonary disease	4.1e-05	0.000435	CcSEcCtD
Diclofenac—Headache—Arformoterol—chronic obstructive pulmonary disease	4.08e-05	0.000433	CcSEcCtD
Diclofenac—Headache—Formoterol—chronic obstructive pulmonary disease	4.08e-05	0.000433	CcSEcCtD
Diclofenac—Weight decreased—Prednisone—chronic obstructive pulmonary disease	4.08e-05	0.000433	CcSEcCtD
Diclofenac—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	4.07e-05	0.000432	CcSEcCtD
Diclofenac—Dizziness—Salbutamol—chronic obstructive pulmonary disease	4.07e-05	0.000432	CcSEcCtD
Diclofenac—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	4.07e-05	0.000432	CcSEcCtD
Diclofenac—Vomiting—Montelukast—chronic obstructive pulmonary disease	4.06e-05	0.00043	CcSEcCtD
Diclofenac—Rash—Montelukast—chronic obstructive pulmonary disease	4.02e-05	0.000427	CcSEcCtD
Diclofenac—Dermatitis—Montelukast—chronic obstructive pulmonary disease	4.02e-05	0.000427	CcSEcCtD
Diclofenac—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	4.01e-05	0.000426	CcSEcCtD
Diclofenac—Depression—Prednisone—chronic obstructive pulmonary disease	4.01e-05	0.000425	CcSEcCtD
Diclofenac—Headache—Montelukast—chronic obstructive pulmonary disease	4e-05	0.000424	CcSEcCtD
Diclofenac—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	3.96e-05	0.00042	CcSEcCtD
Diclofenac—Angioedema—Prednisolone—chronic obstructive pulmonary disease	3.95e-05	0.000419	CcSEcCtD
Diclofenac—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	3.94e-05	0.000418	CcSEcCtD
Diclofenac—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	3.94e-05	0.000418	CcSEcCtD
Diclofenac—Vomiting—Salbutamol—chronic obstructive pulmonary disease	3.91e-05	0.000415	CcSEcCtD
Diclofenac—Malaise—Prednisolone—chronic obstructive pulmonary disease	3.9e-05	0.000414	CcSEcCtD
Diclofenac—Vertigo—Prednisolone—chronic obstructive pulmonary disease	3.88e-05	0.000412	CcSEcCtD
Diclofenac—Rash—Salbutamol—chronic obstructive pulmonary disease	3.88e-05	0.000412	CcSEcCtD
Diclofenac—Syncope—Prednisolone—chronic obstructive pulmonary disease	3.88e-05	0.000411	CcSEcCtD
Diclofenac—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	3.87e-05	0.000411	CcSEcCtD
Diclofenac—Nausea—Arformoterol—chronic obstructive pulmonary disease	3.87e-05	0.000411	CcSEcCtD
Diclofenac—Nausea—Formoterol—chronic obstructive pulmonary disease	3.87e-05	0.000411	CcSEcCtD
Diclofenac—Headache—Salbutamol—chronic obstructive pulmonary disease	3.85e-05	0.000409	CcSEcCtD
Diclofenac—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	3.8e-05	0.000403	CcSEcCtD
Diclofenac—Nausea—Montelukast—chronic obstructive pulmonary disease	3.79e-05	0.000402	CcSEcCtD
Diclofenac—Convulsion—Prednisolone—chronic obstructive pulmonary disease	3.74e-05	0.000397	CcSEcCtD
Diclofenac—Hypertension—Prednisolone—chronic obstructive pulmonary disease	3.73e-05	0.000396	CcSEcCtD
Diclofenac—Bradycardia—Prednisone—chronic obstructive pulmonary disease	3.67e-05	0.00039	CcSEcCtD
Diclofenac—Nausea—Salbutamol—chronic obstructive pulmonary disease	3.65e-05	0.000388	CcSEcCtD
Diclofenac—Discomfort—Prednisolone—chronic obstructive pulmonary disease	3.64e-05	0.000386	CcSEcCtD
Diclofenac—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	3.63e-05	0.000385	CcSEcCtD
Diclofenac—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	3.61e-05	0.000383	CcSEcCtD
Diclofenac—Hallucination—Prednisone—chronic obstructive pulmonary disease	3.59e-05	0.000381	CcSEcCtD
Diclofenac—Oedema—Prednisolone—chronic obstructive pulmonary disease	3.53e-05	0.000374	CcSEcCtD
Diclofenac—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	3.53e-05	0.000374	CcSEcCtD
Diclofenac—Shock—Prednisolone—chronic obstructive pulmonary disease	3.47e-05	0.000368	CcSEcCtD
Diclofenac—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	3.44e-05	0.000365	CcSEcCtD
Diclofenac—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	3.41e-05	0.000362	CcSEcCtD
Diclofenac—Eye disorder—Prednisone—chronic obstructive pulmonary disease	3.37e-05	0.000358	CcSEcCtD
Diclofenac—Flushing—Prednisone—chronic obstructive pulmonary disease	3.35e-05	0.000355	CcSEcCtD
Diclofenac—Angiopathy—Prednisone—chronic obstructive pulmonary disease	3.27e-05	0.000347	CcSEcCtD
Diclofenac—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	3.26e-05	0.000346	CcSEcCtD
Diclofenac—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	3.22e-05	0.000342	CcSEcCtD
Diclofenac—Insomnia—Prednisolone—chronic obstructive pulmonary disease	3.19e-05	0.000339	CcSEcCtD
Diclofenac—Alopecia—Prednisone—chronic obstructive pulmonary disease	3.19e-05	0.000338	CcSEcCtD
Diclofenac—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	3.17e-05	0.000336	CcSEcCtD
Diclofenac—Mental disorder—Prednisone—chronic obstructive pulmonary disease	3.16e-05	0.000335	CcSEcCtD
Diclofenac—Malnutrition—Prednisone—chronic obstructive pulmonary disease	3.14e-05	0.000333	CcSEcCtD
Diclofenac—Erythema—Prednisone—chronic obstructive pulmonary disease	3.14e-05	0.000333	CcSEcCtD
Diclofenac—Pain—Prednisolone—chronic obstructive pulmonary disease	3.02e-05	0.00032	CcSEcCtD
Diclofenac—Vision blurred—Prednisone—chronic obstructive pulmonary disease	2.96e-05	0.000314	CcSEcCtD
Diclofenac—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	2.91e-05	0.000309	CcSEcCtD
Diclofenac—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	2.91e-05	0.000308	CcSEcCtD
Diclofenac—Anaemia—Prednisone—chronic obstructive pulmonary disease	2.9e-05	0.000308	CcSEcCtD
Diclofenac—Agitation—Prednisone—chronic obstructive pulmonary disease	2.89e-05	0.000306	CcSEcCtD
Diclofenac—Angioedema—Prednisone—chronic obstructive pulmonary disease	2.87e-05	0.000305	CcSEcCtD
Diclofenac—Malaise—Prednisone—chronic obstructive pulmonary disease	2.83e-05	0.000301	CcSEcCtD
Diclofenac—Vertigo—Prednisone—chronic obstructive pulmonary disease	2.82e-05	0.000299	CcSEcCtD
Diclofenac—Syncope—Prednisone—chronic obstructive pulmonary disease	2.82e-05	0.000299	CcSEcCtD
Diclofenac—Urticaria—Prednisolone—chronic obstructive pulmonary disease	2.8e-05	0.000297	CcSEcCtD
Diclofenac—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	2.76e-05	0.000293	CcSEcCtD
Diclofenac—Convulsion—Prednisone—chronic obstructive pulmonary disease	2.72e-05	0.000289	CcSEcCtD
Diclofenac—Hypertension—Prednisone—chronic obstructive pulmonary disease	2.71e-05	0.000288	CcSEcCtD
Diclofenac—Arthralgia—Prednisone—chronic obstructive pulmonary disease	2.67e-05	0.000284	CcSEcCtD
Diclofenac—Myalgia—Prednisone—chronic obstructive pulmonary disease	2.67e-05	0.000284	CcSEcCtD
Diclofenac—Anxiety—Prednisone—chronic obstructive pulmonary disease	2.66e-05	0.000283	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	2.66e-05	0.000282	CcSEcCtD
Diclofenac—Discomfort—Prednisone—chronic obstructive pulmonary disease	2.64e-05	0.00028	CcSEcCtD
Diclofenac—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	2.6e-05	0.000276	CcSEcCtD
Diclofenac—Oedema—Prednisone—chronic obstructive pulmonary disease	2.56e-05	0.000272	CcSEcCtD
Diclofenac—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	2.56e-05	0.000272	CcSEcCtD
Diclofenac—Infection—Prednisone—chronic obstructive pulmonary disease	2.55e-05	0.00027	CcSEcCtD
Diclofenac—Shock—Prednisone—chronic obstructive pulmonary disease	2.52e-05	0.000268	CcSEcCtD
Diclofenac—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	2.51e-05	0.000267	CcSEcCtD
Diclofenac—Tachycardia—Prednisone—chronic obstructive pulmonary disease	2.5e-05	0.000265	CcSEcCtD
Diclofenac—Skin disorder—Prednisone—chronic obstructive pulmonary disease	2.49e-05	0.000264	CcSEcCtD
Diclofenac—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	2.48e-05	0.000263	CcSEcCtD
Diclofenac—Anorexia—Prednisone—chronic obstructive pulmonary disease	2.44e-05	0.000259	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	2.34e-05	0.000248	CcSEcCtD
Diclofenac—Dizziness—Prednisolone—chronic obstructive pulmonary disease	2.33e-05	0.000248	CcSEcCtD
Diclofenac—Insomnia—Prednisone—chronic obstructive pulmonary disease	2.32e-05	0.000246	CcSEcCtD
Diclofenac—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	2.3e-05	0.000244	CcSEcCtD
Diclofenac—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	2.26e-05	0.000239	CcSEcCtD
Diclofenac—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	2.23e-05	0.000236	CcSEcCtD
Diclofenac—Rash—Prednisolone—chronic obstructive pulmonary disease	2.22e-05	0.000236	CcSEcCtD
Diclofenac—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	2.22e-05	0.000236	CcSEcCtD
Diclofenac—Fatigue—Prednisone—chronic obstructive pulmonary disease	2.21e-05	0.000235	CcSEcCtD
Diclofenac—Headache—Prednisolone—chronic obstructive pulmonary disease	2.21e-05	0.000235	CcSEcCtD
Diclofenac—Constipation—Prednisone—chronic obstructive pulmonary disease	2.19e-05	0.000233	CcSEcCtD
Diclofenac—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	2.11e-05	0.000224	CcSEcCtD
Diclofenac—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	2.1e-05	0.000222	CcSEcCtD
Diclofenac—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.1e-05	0.000222	CcSEcCtD
Diclofenac—Urticaria—Prednisone—chronic obstructive pulmonary disease	2.04e-05	0.000216	CcSEcCtD
Diclofenac—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	2.03e-05	0.000215	CcSEcCtD
Diclofenac—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	2.03e-05	0.000215	CcSEcCtD
Diclofenac—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	1.89e-05	0.0002	CcSEcCtD
Diclofenac—Asthenia—Prednisone—chronic obstructive pulmonary disease	1.84e-05	0.000195	CcSEcCtD
Diclofenac—Pruritus—Prednisone—chronic obstructive pulmonary disease	1.81e-05	0.000192	CcSEcCtD
Diclofenac—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	1.75e-05	0.000186	CcSEcCtD
Diclofenac—Dizziness—Prednisone—chronic obstructive pulmonary disease	1.69e-05	0.00018	CcSEcCtD
Diclofenac—Vomiting—Prednisone—chronic obstructive pulmonary disease	1.63e-05	0.000173	CcSEcCtD
Diclofenac—Rash—Prednisone—chronic obstructive pulmonary disease	1.62e-05	0.000172	CcSEcCtD
Diclofenac—Dermatitis—Prednisone—chronic obstructive pulmonary disease	1.61e-05	0.000171	CcSEcCtD
Diclofenac—Headache—Prednisone—chronic obstructive pulmonary disease	1.61e-05	0.00017	CcSEcCtD
Diclofenac—Nausea—Prednisone—chronic obstructive pulmonary disease	1.52e-05	0.000162	CcSEcCtD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.79e-06	0.000123	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.79e-06	0.000123	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.79e-06	0.000123	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.73e-06	0.000122	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.72e-06	0.000122	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.7e-06	0.000122	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.68e-06	0.000121	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.68e-06	0.000121	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	6.66e-06	0.000121	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.6e-06	0.00012	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.54e-06	0.000119	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	6.53e-06	0.000119	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.51e-06	0.000118	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	6.5e-06	0.000118	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.43e-06	0.000117	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.31e-06	0.000115	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.25e-06	0.000113	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.24e-06	0.000113	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.24e-06	0.000113	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.24e-06	0.000113	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	6.22e-06	0.000113	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.2e-06	0.000113	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.19e-06	0.000112	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.19e-06	0.000112	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.16e-06	0.000112	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	6.07e-06	0.00011	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.07e-06	0.00011	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.04e-06	0.00011	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.99e-06	0.000109	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—ALB—chronic obstructive pulmonary disease	5.97e-06	0.000108	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.92e-06	0.000107	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.91e-06	0.000107	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.86e-06	0.000106	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.82e-06	0.000106	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.76e-06	0.000105	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.75e-06	0.000104	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.74e-06	0.000104	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.74e-06	0.000104	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.72e-06	0.000104	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.69e-06	0.000103	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.65e-06	0.000103	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.6e-06	0.000102	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.6e-06	0.000102	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.53e-06	0.0001	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.5e-06	9.99e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.5e-06	9.98e-05	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	5.49e-06	9.96e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	5.42e-06	9.83e-05	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.4e-06	9.81e-05	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.39e-06	9.79e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.39e-06	9.79e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.37e-06	9.74e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.34e-06	9.69e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	5.32e-06	9.65e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.29e-06	9.61e-05	CbGpPWpGaD
Diclofenac—TTR—Disease—TGFB1—chronic obstructive pulmonary disease	5.29e-06	9.6e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.25e-06	9.52e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	5.22e-06	9.48e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	5.19e-06	9.42e-05	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.18e-06	9.41e-05	CbGpPWpGaD
Diclofenac—TTR—Disease—EGFR—chronic obstructive pulmonary disease	5.18e-06	9.41e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.18e-06	9.39e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.1e-06	9.26e-05	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	5.04e-06	9.14e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	5.03e-06	9.13e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.01e-06	9.1e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.01e-06	9.1e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.97e-06	9.02e-05	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.96e-06	9e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.95e-06	8.99e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.93e-06	8.96e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.93e-06	8.95e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	4.88e-06	8.86e-05	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.86e-06	8.83e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.83e-06	8.76e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.82e-06	8.74e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	4.76e-06	8.64e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.76e-06	8.63e-05	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	4.72e-06	8.57e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.72e-06	8.56e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.68e-06	8.49e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KL—chronic obstructive pulmonary disease	4.68e-06	8.49e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.66e-06	8.46e-05	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.63e-06	8.41e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.62e-06	8.38e-05	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.53e-06	8.22e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.52e-06	8.2e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.51e-06	8.18e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.5e-06	8.17e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.49e-06	8.15e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.45e-06	8.07e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.4e-06	7.98e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.38e-06	7.94e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	4.35e-06	7.9e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.34e-06	7.89e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.31e-06	7.83e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.25e-06	7.72e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.16e-06	7.56e-05	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.15e-06	7.53e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.12e-06	7.48e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.12e-06	7.47e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	4.11e-06	7.46e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.1e-06	7.44e-05	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.08e-06	7.41e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.08e-06	7.4e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.05e-06	7.36e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.03e-06	7.32e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	4.03e-06	7.32e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.02e-06	7.3e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	4.02e-06	7.3e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.01e-06	7.28e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	4.01e-06	7.27e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.01e-06	7.27e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4e-06	7.27e-05	CbGpPWpGaD
Diclofenac—TTR—Disease—IL6—chronic obstructive pulmonary disease	3.98e-06	7.23e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.93e-06	7.14e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.93e-06	7.13e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.92e-06	7.12e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	3.91e-06	7.1e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	3.85e-06	6.98e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.84e-06	6.98e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.81e-06	6.92e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.76e-06	6.82e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.76e-06	6.82e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	3.74e-06	6.79e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.72e-06	6.76e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.7e-06	6.72e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.7e-06	6.71e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	3.68e-06	6.68e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	3.67e-06	6.66e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	3.66e-06	6.64e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.64e-06	6.61e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.63e-06	6.59e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	3.6e-06	6.53e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.55e-06	6.45e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.51e-06	6.37e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	3.5e-06	6.36e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	3.5e-06	6.35e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.47e-06	6.3e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.43e-06	6.22e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.39e-06	6.15e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.37e-06	6.12e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.35e-06	6.09e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.34e-06	6.06e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.32e-06	6.02e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.29e-06	5.98e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	3.28e-06	5.96e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.28e-06	5.95e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.27e-06	5.93e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.22e-06	5.85e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.2e-06	5.82e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.19e-06	5.79e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.18e-06	5.77e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.17e-06	5.75e-05	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.11e-06	5.65e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.08e-06	5.6e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.07e-06	5.57e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	3.06e-06	5.56e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.06e-06	5.55e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.05e-06	5.53e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.04e-06	5.52e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.04e-06	5.52e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.03e-06	5.49e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.02e-06	5.49e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.01e-06	5.47e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3e-06	5.45e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.99e-06	5.43e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.95e-06	5.36e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.93e-06	5.32e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	2.92e-06	5.3e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.91e-06	5.28e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.85e-06	5.17e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.84e-06	5.15e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.83e-06	5.14e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.83e-06	5.13e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.83e-06	5.13e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.81e-06	5.1e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.8e-06	5.09e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.79e-06	5.06e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.79e-06	5.06e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.77e-06	5.03e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.76e-06	5.01e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.71e-06	4.91e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.61e-06	4.74e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.6e-06	4.71e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.6e-06	4.71e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	2.59e-06	4.7e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.58e-06	4.69e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.56e-06	4.64e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.52e-06	4.58e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.49e-06	4.52e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.48e-06	4.51e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.48e-06	4.5e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.46e-06	4.47e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.46e-06	4.47e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	2.46e-06	4.47e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.45e-06	4.44e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.43e-06	4.42e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.43e-06	4.41e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	2.35e-06	4.26e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.32e-06	4.21e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	2.31e-06	4.2e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.3e-06	4.18e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	2.27e-06	4.12e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.27e-06	4.12e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.26e-06	4.11e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.2e-06	3.99e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.19e-06	3.97e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.16e-06	3.93e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.14e-06	3.89e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	2.14e-06	3.88e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.11e-06	3.84e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	2.06e-06	3.73e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.04e-06	3.71e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2e-06	3.64e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	1.98e-06	3.59e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.97e-06	3.58e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.97e-06	3.57e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.97e-06	3.57e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.94e-06	3.52e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.94e-06	3.51e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.89e-06	3.43e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.87e-06	3.4e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.85e-06	3.36e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.83e-06	3.31e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.82e-06	3.3e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.81e-06	3.28e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.75e-06	3.17e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	1.74e-06	3.17e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.71e-06	3.11e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.67e-06	3.04e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.6e-06	2.91e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	1.59e-06	2.89e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	1.55e-06	2.82e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	1.52e-06	2.76e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.52e-06	2.75e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.5e-06	2.72e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.49e-06	2.71e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.46e-06	2.65e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.43e-06	2.59e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.39e-06	2.53e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.39e-06	2.53e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.36e-06	2.47e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.32e-06	2.4e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.3e-06	2.36e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	1.17e-06	2.12e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.16e-06	2.11e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.11e-06	2.02e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	8.98e-07	1.63e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	8.59e-07	1.56e-05	CbGpPWpGaD
